{"id":587915,"date":"2025-08-14T22:24:02","date_gmt":"2025-08-15T05:24:02","guid":{"rendered":"https:\/\/nai500.com\/?p=587915"},"modified":"2025-08-14T22:24:02","modified_gmt":"2025-08-15T05:24:02","slug":"%e7%94%9f%e7%89%a9%e7%a7%91%e6%8a%80etf%e6%8a%95%e8%b5%84%e6%8c%87%e5%8d%97%ef%bc%9a%e5%9b%9b%e5%8f%aa%e4%bc%98%e9%80%89%e5%9f%ba%e9%87%91%e8%a7%a3%e6%9e%90","status":"publish","type":"post","link":"https:\/\/nai500.com\/zh-hans\/blog\/2025\/08\/%e7%94%9f%e7%89%a9%e7%a7%91%e6%8a%80etf%e6%8a%95%e8%b5%84%e6%8c%87%e5%8d%97%ef%bc%9a%e5%9b%9b%e5%8f%aa%e4%bc%98%e9%80%89%e5%9f%ba%e9%87%91%e8%a7%a3%e6%9e%90\/","title":{"rendered":"\u751f\u7269\u79d1\u6280ETF\u6295\u8d44\u6307\u5357\uff1a\u56db\u53ea\u4f18\u9009\u57fa\u91d1\u89e3\u6790"},"content":{"rendered":"<p>2025\u5e74\u4ee5\u6765\uff0c\u751f\u7269\u79d1\u6280\u884c\u4e1a\u6301\u7eed\u627f\u538b\u3002\u5c3d\u7ba1\u5982\u6b64\uff0c\u751f\u7269\u79d1\u6280\u80a1\u7968\u4ecd\u4ee5\u9ad8\u6210\u957f\u6f5c\u529b\u5438\u5f15\u6295\u8d44\u8005\uff0c\u77ed\u671f\u4f30\u503c\u4f18\u52bf\u65e5\u76ca\u660e\u663e\uff0c\u800cAI\u9a71\u52a8\u7684\u836f\u7269\u7814\u53d1\u4ecd\u662f\u4e2d\u957f\u671f\u80a1\u4ef7\u4e0a\u6da8\u7684\u50ac\u5316\u5242\u3002\u4f46\u662f\uff0c\u5355\u4e00\u516c\u53f8\u7684\u6295\u8d44\u98ce\u9669\u5de8\u5927\uff0c\u751f\u7269\u79d1\u6280\u4ea4\u6613\u6240\u4ea4\u6613\u57fa\u91d1\uff08ETF\uff09\u80fd\u6709\u6548\u5206\u6563\u98ce\u9669\uff0c\u662f\u53c2\u4e0e\u8be5\u9886\u57df\u957f\u671f\u589e\u957f\u7684\u7406\u6027\u5de5\u5177\u3002<\/p>\n<p>\u751f\u7269\u79d1\u6280\u884c\u4e1a\u5b58\u5728\u4e24\u7c7b\u622a\u7136\u4e0d\u540c\u7684\u4f01\u4e1a\uff1a\u4e00\u65b9\u9762\uff0c\u5b89\u8fdb\uff08AMGN\uff09\u3001\u5409\u5229\u5fb7\u79d1\u5b66\uff08GILD\uff09\u3001\u798f\u6cf0\u5236\u836f\uff08VRTX\uff09\u548c\u518d\u751f\u5143\u5236\u836f\uff08REGN\uff09\u7b49\u5927\u578b\u84dd\u7b79\u4f01\u4e1a\u5904\u4e8e\u5546\u4e1a\u9636\u6bb5\uff0c\u53ef\u4ee5\u901a\u8fc7\u9500\u552e\u836f\u7269\u83b7\u5f97\u7a33\u5b9a\u7684\u76c8\u5229\u548c\u73b0\u91d1\u6d41\uff0c\u7528\u4e8e\u6301\u7eed\u7814\u53d1\u3001\u5408\u4f5c\u3001\u80a1\u7968\u56de\u8d2d\u6216\u5206\u7ea2\u3002\u53e6\u4e00\u65b9\u9762\uff0c\u4e34\u5e8a\u9636\u6bb5\u7684\u751f\u7269\u79d1\u6280\u516c\u53f8\u901a\u5e38\u4e3a\u4e2d\u5c0f\u5e02\u503c\u516c\u53f8\uff0c\u6536\u5165\u5fae\u8584\u751a\u81f3\u6ca1\u6709\u6536\u5165\uff0c\u4f9d\u8d56\u73b0\u91d1\u50a8\u5907\u63a8\u8fdb\u836f\u7269\u8bd5\u9a8c\u3002\u8fd9\u7c7b\u516c\u53f8\u7684\u56de\u62a5\u5177\u6709\u6781\u7aef\u7684\u201c\u4e8c\u5143\u5316\u201d\u7279\u5f81\uff1a\u53ef\u80fd\u5728\u591a\u5e74\u6d88\u8017\u73b0\u91d1\u548c\u7a00\u91ca\u80a1\u6743\u540e\u56e0\u8bd5\u9a8c\u6210\u529f\u6216\u836f\u7269\u83b7\u6279\u800c\u80a1\u4ef7\u500d\u589e\uff0c\u4f46\u66f4\u591a\u4f1a\u56e0\u4e3a\u8bd5\u9a8c\u5931\u8d25\u6216\u76d1\u7ba1\u632b\u6298\u5bfc\u81f4\u4f30\u503c\u5d29\u6e83\u3002<\/p>\n<p>\u751f\u7269\u79d1\u6280\u516c\u53f8\u5931\u8d25\u98ce\u9669\u5f88\u9ad8\uff0c\u521b\u65b0\u9700\u7ecf\u5386\u591a\u5e74\u7684\u4e34\u5e8a\u8bd5\u9a8c\uff0c\u4e00\u6b21\u5931\u8d25\u5c31\u53ef\u80fd\u6467\u6bc1\u516c\u53f8\u3002\u56e0\u6b64\uff0c\u8be5\u9886\u57df\u7684\u56de\u62a5\u5dee\u5f02\u5de8\u5927\uff0c\u6311\u9009\u8d62\u5bb6\u4e2a\u80a1\u6781\u5176\u56f0\u96be\u4e14\u98ce\u9669\u5de8\u5927\u3002\u8fd9\u65f6\u5019\u6295\u8d44\u751f\u7269\u79d1\u6280ETF\u6709\u52a9\u4e8e\u5bf9\u51b2\u8d1f\u9762\u4e8b\u4ef6\u98ce\u9669\uff0c\u540c\u65f6\u4ecd\u80fd\u663e\u8457\u53d7\u76ca\u4e8e\u533b\u7597\u4fdd\u5065\u884c\u4e1a\u7684\u957f\u671f\u7ed3\u6784\u6027\u8f6c\u53d8\u3002<\/p>\n<h2>\u56db\u53ea\u4f18\u9009\u751f\u7269\u79d1\u6280ETF<\/h2>\n<table>\n<thead>\n<tr>\n<td><strong>ETF\u540d\u79f0<\/strong><\/td>\n<td><strong>\u8d39\u7387<\/strong><\/td>\n<td><strong>\u6838\u5fc3\u7279\u5f81<\/strong><\/td>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td><strong><a href=\"https:\/\/nai500.com\/zh-hant\/%e8%82%a1%e7%a5%a8%e6%9f%a5%e8%a9%a2\/?qm_symbol=IBB\">iShares\u751f\u7269\u79d1\u6280ETF (IBB)<\/a><\/strong><\/td>\n<td>0.44%<\/td>\n<td>&#8211; \u8ddf\u8e2a\u5e02\u503c\u52a0\u6743\u6307\u6570\uff0c\u91cd\u4ed3\u5b89\u8fdb\/\u5409\u5229\u5fb7\u7b49\u5de8\u5934<br \/>\n&#8211; \u4e09\u5e74\u8d1d\u5854\u503c0.8\uff0c\u6ce2\u52a8\u4f4e\u4e8e\u5927\u76d8<\/td>\n<\/tr>\n<tr>\n<td><strong>First Trust NYSE Arca\u751f\u7269\u79d1\u6280\u6307\u6570\u57fa\u91d1 (FBT)<\/strong><\/td>\n<td>0.54%<\/td>\n<td>&#8211; \u6309\u8425\u6536\u3001\u7814\u53d1\u6295\u5165\u7b49\u57fa\u672c\u9762\u6307\u6807\u7b5b\u9009\u6210\u4efd\u80a1<br \/>\n&#8211; \u4ec5\u7eb3\u5165\u8bc4\u5206\u524d30\u540d\u7684\u4f01\u4e1a<\/td>\n<\/tr>\n<tr>\n<td><strong>\u666f\u987a\u7eb3\u65af\u8fbe\u514b\u751f\u7269\u79d1\u6280ETF (IBBQ)<\/strong><\/td>\n<td>0.19%<\/td>\n<td>&#8211; \u8986\u76d6\u7eb3\u65af\u8fbe\u514b200\u4f59\u5bb6\u751f\u7269\u533b\u836f\u80a1<br \/>\n&#8211; \u4e0eIBB\u6301\u4ed3\u91cd\u53e0\u738780%\uff0c\u9002\u5408\u7a0e\u6536\u635f\u5931\u6536\u5272\u7b56\u7565<\/td>\n<\/tr>\n<tr>\n<td><strong>\u5168\u7403X\u57fa\u56e0\u7ec4\u5b66\u548c\u751f\u7269\u79d1\u6280ETF (GNOM)<\/strong><\/td>\n<td>0.50%<\/td>\n<td>&#8211; \u4e13\u6ce8\u57fa\u56e0\u7f16\u8f91\u3001\u6d4b\u5e8f\u7b49\u7ec6\u5206\u9886\u57df<br \/>\n&#8211; \u6301\u4ed3\u4ee5\u4e2d\u578b\u4f01\u4e1a\u4e3a\u4e3b\uff0c\u5982CRISPR(CRSP)\u3001Illumina (ILMN)<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p>\u4ee5\u4e0b\u662f\u8fd9\u56db\u53ea\u4f18\u9009\u751f\u7269\u79d1\u6280ETF\u7684\u5177\u4f53\u5206\u6790\uff1a<\/p>\n<ol>\n<li><strong>iShares\u751f\u7269\u79d1\u6280ETF (IBB) (\u8d39\u7387\uff1a0.44%)\uff1a<\/strong>\u00a0IBB\u8ddf\u8e2a\u5e02\u503c\u52a0\u6743\u7684\u7ebd\u4ea4\u6240\u751f\u7269\u79d1\u6280\u6307\u6570NYSE Biotechnology Index\uff0c\u5b89\u8fdb\u3001\u5409\u5229\u5fb7\u548c\u518d\u751f\u5143\u7b49\u5927\u578b\u7a33\u5b9a\u7684\u516c\u53f8\u5360\u636e\u4e3b\u8981\u6301\u4ed3\u3002\u56e0\u6b64\uff0c\u8be5\u57fa\u91d1\u6ce2\u52a8\u6027\u7565\u4f4e\u4e8e\u5927\u76d8\uff0c\u4e09\u5e74\u8d1d\u5854\u503c\u4e3a0.8\uff0c\u662f\u751f\u7269\u79d1\u6280\u6295\u8d44\u65b0\u624b\u7684\u7406\u60f3\u9009\u62e9\u3002<\/li>\n<li><strong>First Trust NYSE Arca Biotechnology Index Fund (FBT) (\u8d39\u7387\uff1a0.54%)\uff1a<\/strong>\u00a0FBT\u901a\u8fc7NYSE Arca Biotechnology Index\u63d0\u4f9b\u4e0d\u540c\u7684\u6295\u8d44\u655e\u53e3\u3002\u8be5\u6307\u6570\u5e76\u975e\u4ec5\u6309\u5e02\u503c\u52a0\u6743\uff0c\u800c\u662f\u6839\u636e12\u4e2a\u6708\u6536\u5165\u3001\u51c0\u9500\u552e\u989d\u4e0e\u7814\u53d1\u8d39\u7528\u6bd4\u7387\u4ee5\u53ca12\u4e2a\u6708\u7814\u53d1\u652f\u51fa\u7684\u767e\u5206\u6bd4\u53d8\u5316\u5bf9\u7b26\u5408\u6761\u4ef6\u7684\u6210\u5206\u80a1\u8fdb\u884c\u6392\u540d\uff0c\u9009\u53d6\u5f97\u5206\u6700\u9ad8\u768430\u53ea\u80a1\u7968\u7eb3\u5165\u3002\u8fd9\u79cd\u66f4\u590d\u6742\u7684\u9009\u80a1\u65b9\u6cd5\u5e26\u6765\u4e86\u76f8\u5bf9\u8f83\u9ad8\u7684\u8d39\u7387\u3002<\/li>\n<li><strong>\u666f\u987a\u7eb3\u65af\u8fbe\u514b\u751f\u7269\u79d1\u6280ETF (IBBQ) (\u8d39\u7387\uff1a0.19%)\uff1a<\/strong>\u00a0IBBQ\u8ddf\u8e2a\u7eb3\u65af\u8fbe\u514b\u751f\u7269\u6280\u672f\u6307\u6570\uff0c\u8986\u76d6\u5728\u7eb3\u65af\u8fbe\u514b\u4ea4\u6613\u6240\u4e0a\u5e02\u7684\u6240\u6709\u751f\u7269\u6280\u672f\u548c\u5236\u836f\u80a1\uff0c\u8be5\u57fa\u51c6\u62e5\u6709\u8d85\u8fc730\u5e74\u7684\u8ddf\u8e2a\u8bb0\u5f55\u5e76\u6301\u6709200\u591a\u53ea\u80a1\u7968\u3002\u4e0eIBB\u7c7b\u4f3c\uff0c\u7531\u4e8e\u91c7\u7528\u5e02\u503c\u52a0\u6743\u65b9\u6cd5\uff0c\u5409\u5229\u5fb7\u3001\u5b89\u8fdb\u3001\u798f\u6cf0\u548c\u518d\u751f\u5143\u540c\u6837\u662f\u4e3b\u8981\u6301\u4ed3\u3002\u5c3d\u7ba1\u8ddf\u8e2a\u7eb3\u65af\u8fbe\u514b\u548c\u7ebd\u4ea4\u6240\u7684\u4e0d\u540c\u6307\u6570\uff0cIBBQ\u548cIBB\u7684\u6295\u8d44\u7ec4\u5408\u9ad8\u5ea6\u76f8\u4f3c\uff0c\u91cd\u53e0\u7387\u7ea680%\u3002\u8fd9\u79cd\u9ad8\u5ea6\u76f8\u4f3c\u6027\u4f7f\u5176\u6210\u4e3a\u7406\u60f3\u7684\u7a0e\u6536\u635f\u5931\u6536\u5272\uff08tax-loss harvesting\uff09\u642d\u6863\u3002<\/li>\n<li><strong>Global X Genomics &amp; Biotechnology ETF (GNOM) (\u8d39\u7387\uff1a0.50%)\uff1a<\/strong>\u00a0GNOM\u4e13\u95e8\u7eb3\u5165\u57fa\u56e0\u7ec4\u5b66\u516c\u53f8\uff0c\u5373\u6bcf\u5bb6\u516c\u53f8\u81f3\u5c1150%\u7684\u73b0\u6709\u6216\u9884\u671f\u6536\u5165\u9700\u6765\u81ea\u57fa\u56e0\u7f16\u8f91\u3001\u57fa\u56e0\u7ec4\u6d4b\u5e8f\u3001\u57fa\u56e0\u836f\u7269\u548c\u7597\u6cd5\uff0c\u6216\u8ba1\u7b97\u57fa\u56e0\u7ec4\u5b66\u4e0e\u57fa\u56e0\u8bca\u65ad\u3002\u4e0d\u540c\u4e8eIBBQ\u548cIBB\uff0cGNOM\u7684\u6295\u8d44\u7ec4\u5408\u5305\u542b\u66f4\u591a\u65b0\u5174\u7684\u4e2d\u578b\u751f\u7269\u79d1\u6280\u516c\u53f8\uff0c\u5982\u5f00\u53d1\u57fa\u56e0\u7f16\u8f91\u7597\u6cd5\u7684CRISPR Therapeutics AG (CRSP)\uff0c\u4ee5\u53ca\u57fa\u56e0\u6d4b\u5e8f\u9f99\u5934Illumina\uff08ILMN\uff09\u3002<\/li>\n<\/ol>\n","protected":false},"excerpt":{"rendered":"<p>2025\u5e74\u4ee5\u6765\uff0c\u751f\u7269\u79d1\u6280\u884c\u4e1a\u6301\u7eed\u627f\u538b\u3002\u5c3d\u7ba1\u5982\u6b64\uff0c\u751f\u7269\u79d1\u6280\u80a1\u7968\u4ecd\u4ee5\u9ad8\u6210\u957f\u6f5c\u529b\u5438\u5f15\u6295\u8d44\u8005\uff0c\u77ed\u671f\u4f30\u503c\u4f18\u52bf\u65e5\u76ca\u660e\u663e\uff0c\u800c [&hellip;]<\/p>\n","protected":false},"author":27,"featured_media":555083,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":"","_links_to":"","_links_to_target":""},"categories":[1521,430],"tags":[2190,455,747,925],"class_list":["post-587915","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-1521","category-trends-strategies-zh-hans","tag-etf-sch","tag-455","tag-747","tag-925","sectors-life-science-zh-hans","locations-us-zh-hans","exchange-nasdaq-zh-hans","exchange-nyse-zh-hans"],"acf":[],"_links":{"self":[{"href":"https:\/\/nai500.com\/zh-hans\/wp-json\/wp\/v2\/posts\/587915","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/nai500.com\/zh-hans\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/nai500.com\/zh-hans\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/nai500.com\/zh-hans\/wp-json\/wp\/v2\/users\/27"}],"replies":[{"embeddable":true,"href":"https:\/\/nai500.com\/zh-hans\/wp-json\/wp\/v2\/comments?post=587915"}],"version-history":[{"count":1,"href":"https:\/\/nai500.com\/zh-hans\/wp-json\/wp\/v2\/posts\/587915\/revisions"}],"predecessor-version":[{"id":587920,"href":"https:\/\/nai500.com\/zh-hans\/wp-json\/wp\/v2\/posts\/587915\/revisions\/587920"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/nai500.com\/zh-hans\/wp-json\/wp\/v2\/media\/555083"}],"wp:attachment":[{"href":"https:\/\/nai500.com\/zh-hans\/wp-json\/wp\/v2\/media?parent=587915"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/nai500.com\/zh-hans\/wp-json\/wp\/v2\/categories?post=587915"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/nai500.com\/zh-hans\/wp-json\/wp\/v2\/tags?post=587915"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}